Harvard Bioscience

Improves liquidity and operating flexibility Significantly reduces borrowing costs Supports ongoing transformation to profitable growth platform HOLLISTON, Mass., Dec. 22,

HOLLISTON, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO), today announced that Jim Green, Chairman, President

Disciplined cost management, cash conservation actions drive increased year-over-year operating income and reduced net debt Operating margin up year-over-year on

HOLLISTON, MA., Oct. 20, 2020 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third

HOLLISTON, Mass., Sept. 16, 2020 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, President and CEO, will

Accelerated cost reduction, cash conservation actions drive increased operating income, reduced net debt Operating Income up sequentially and year-over-year on

HOLLISTON, Mass., July 20, 2020 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second

Provides Update on Performance Against Previously Announced Strategic Plan HOLLISTON, Mass., May 26, 2020 (GLOBE NEWSWIRE) — Jim Green, Chairman,

Implemented significant cost reductions to offset Covid-19 impact on operating income HOLLISTON, Mass., May 05, 2020 (GLOBE NEWSWIRE) — Harvard

HOLLISTON, Mass., April 23, 2020 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first

Engine Capital Withdraws Director Nomination Notice For 2020 Annual Meeting of Stockholders HOLLISTON, Mass., April 06, 2020 (GLOBE NEWSWIRE) —

Company will continue to manufacture and ship innovative products for global development and research throughout crisis HOLLISTON, Mass., March 23,

Substantially improves adjusted operating margins while taking actions to underpin 2020 profit and growth targets HOLLISTON, Mass., Feb. 26, 2020

Substantially improves adjusted operating margins while taking actions to underpin 2020 profit and growth targets HOLLISTON, Mass., Feb. 26, 2020

HOLLISTON, Mass., Feb. 11, 2020 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth

HOLLISTON, Mass., Oct. 22, 2019 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its quarterly results for third

HOLLISTON, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Yash Singh has been

HOLLISTON, Mass., Nov. 01, 2019 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that in connection with Yash

Improves adjusted operating margins while taking actions to underpin next year’s profit and growth targets Q3 Revenue of $27.4 million

HOLLISTON, Mass., Nov. 21, 2019 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO), today announced that Jim Green, Chairman, President